LR219

Nebraska LR219 proposes an interim study on nonopioid treatments in Medicaid, assessing access, benefits, and cost savings.

Nebraska LR219 proposes an interim study to examine nonopioid pharmacological treatment options within Medicaid. The study will evaluate opportunities and barriers to accessing these treatments, assess initiatives promoting nonopioid pain management, and investigate potential cost savings due to reduced opioid addiction and death. The Health and Human Services Committee will conduct the study and report findings and recommendations to the Legislative Council or Legislature.